SCHEMBL15664164

SCHEMBL15664164

CCCCCCCCCCCCCCCCCC[C@H](C)[C@H](CCCCCCCCCCCCCCSc1nnnn1-c1ccccc1)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.50
LMNA P02545 8/20 0.48
THRB P10828 2/20 0.48
TSHR P16473 5/20 0.47
HPGD P15428 4/20 0.47
POLB P06746 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
NPC1 O15118 2/20 0.47
NFKB1 P19838 2/20 0.47
RAB9A P51151 2/20 0.47
NFKB2 Q00653 2/20 0.47
RELA Q04206 2/20 0.47
TDP1 Q9NUW8 1/20 0.47
TP53 P04637 4/20 0.45
HSD17B10 Q99714 2/20 0.44
MAPT P10636 2/20 0.44
MAPK1 P28482 2/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17761121 0.84 ALDH1A1 (0.68) ALDH1A1LMNATHRBTSHRHPGD
SCHEMBL24305911 0.84 ALDH1A1 (0.68) ALDH1A1LMNATHRBTSHRHPGD
SCHEMBL16526226 0.83 ALDH1A1 (0.70) ALDH1A1LMNATHRBTSHRHPGD
SCHEMBL18723118 0.82 ALDH1A1 (0.59) ALDH1A1LMNATHRBTSHRHPGD
SCHEMBL17755396 0.81 ALDH1A1 (0.59) ALDH1A1LMNATHRBTSHRHPGD
SCHEMBL16522420 0.80 ALDH1A1 (0.61) ALDH1A1LMNATHRBTSHRHPGD
SCHEMBL16116944 0.80 ALDH1A1 (0.72) ALDH1A1LMNATHRBTSHRHPGD
SCHEMBL18723001 0.79 ALDH1A1 (0.58) ALDH1A1LMNATHRBTSHRHPGD
SCHEMBL15679447 0.79 ALDH1A1 (0.48) ALDH1A1LMNATSHRHPGDNPSR1
SCHEMBL15664141 0.79 ALDH1A1 (0.48) ALDH1A1LMNATSHRHPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9945852-B2 Method for determining the presence or absence of a biomarker ARCIS BIOTECHNOLOGY HOLDINGS LIMITED (GB) 2018-04-17 US disclosed
EP-2705367-B1 METHOD FOR DETERMINING THE PRESENCE OR ABSENCE OF A BIOMARKER BANGOR UNIV (GB) 2017-04-26 EP disclosed
US-20140127709-A1 METHOD FOR DETERMINING THE PRESENCE OR ABSENCE OF A BIOMARKER BANGOR UNIVERSITY (GB) 2014-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140127709-A1 METHOD FOR DETERMINING THE PRESENCE OR ABSENCE OF A BIOMARKER CA14, CD63, CA12 ALDH1A1 1037/4885LMNA 3363/4885THRB 2385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.